For example, in the basic model, glycans such as GP32, GP19, GP22, and GP34 exhibited a consistent upward trend from NGT to prediabetes and T2D, underscoring their potential as early indicators of disease progression. This evidence concerns the gene TNFSF4 and type 2 diabetes mellitus.